Basit öğe kaydını göster

dc.contributor.authorAgbaht, Kemal
dc.contributor.authorPepedil, Funda
dc.contributor.authorKırkpantur, Alper
dc.contributor.authorYılmaz, Rahmi
dc.contributor.authorArıcı, Mustafa
dc.contributor.authorTurgan, Çetin
dc.date.accessioned2019-12-10T11:10:01Z
dc.date.available2019-12-10T11:10:01Z
dc.date.issued2007
dc.identifier.issn0886-022X
dc.identifier.urihttps://doi.org/10.1080/08860220601039551
dc.identifier.urihttp://hdl.handle.net/11655/14791
dc.description.abstractKaposi's sarcoma (KS) is an unusual tumor principally affecting the skin of the lower extremities. Although the association between KS and renal transplant has been well documented, there are a few KS cases in the literature associated with membranoproliferative glomerulonephritis or other glomerular diseases. This report presents a patient with membranoproliferative glomerulonephritis (MPGN) who developed KS following treatment with long-term medium dose glucocorticoid and short-term additional immunosuppressives. The KS cases associated with glomerulonephritis are also reviewed. KS is a rare complication in glomerular diseases that may (or may not) be related to immunosuppression. Hence, immunosuppression treatment should be carefully planned in glomerulonephritis treatment and avoided if they are not essentially necessary.
dc.language.isoen
dc.publisherTaylor & Francis Ltd
dc.relation.isversionof10.1080/08860220601039551
dc.rightsinfo:eu-repo/semantics/openAccess
dc.subjectUrology & Nephrology
dc.titleA Case of Kaposi's Sarcoma Following Treatment of Membranoproliferative Glomerulonephritis and a Review of the Literature
dc.typeinfo:eu-repo/semantics/review
dc.typeinfo:eu-repo/semantics/publishedVersion
dc.relation.journalRenal Failure
dc.contributor.departmentİç Hastalıkları
dc.identifier.volume29
dc.identifier.issue1
dc.identifier.startpage107
dc.identifier.endpage110
dc.description.indexWoS
dc.description.indexScopus


Bu öğenin dosyaları:

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster